The END of Capitalism As We Know It?
A terrifying (for some) and new disruptive force is creating thousands of new millionaires (Barron’s reports 20,000 to 200,000 so far) while at the same time destroying the financial future for many others.
Don’t get left behind. Get the facts for yourself
Stephane  Bancel, insider at Moderna

Stephane Bancel Insider Information

CEO of Moderna

Stéphane Bancel is a French billionaire businessman and the CEO of Moderna Therapeutics, a clinical stage biotechnology company. 

Bancel joined Moderna’s board of directors in 2011, the same year he was brought on as CEO. The biotech company focuses on the discovery and development of messenger RNA therapeutics and vaccines for infectious, immuno-oncology and cardiovascular diseases. 

With Bancel at the helm during the COVID-19 global pandemic, Moderna was one of the first two vaccine developers to receive authorization in the United States. Moderna’s stock price rose in response to the success of the world’s first mRNA vaccine, making Bancel’s stake in the company worth over $1 billion. 

Prior to Moderna, Bancel was the CEO of French diagnostics company, bioMérieux, from 2007-2011. While leading the company, he accelerated bioMérieux’s sales growth rate by pivoting to high-value biomarkers, as well as nearly doubling its market capitalization despite the financial crisis.

He gained experience in the pharmaceutical industry through roles at Eli Lilly including managing director, Belgium and executive director, global manufacturing strategy and supply chain. 

Bancel was elected one of the World Economic Forum’s Young Global Leaders in 2009, Best CEO for Investor Relations in France in 2009, and #1 CEO in the biotechnology sector according to the 2011 Thomson Reuters Pan European EXTEL Study.

Bancel sits on the boards of Qiagen N.V. and Indigo, and he is a venture partner at Flagship Pioneering as well as a trustee for Boston’s Museum of Science. He earned his Master of Engineering degree at École Centrale Paris, his M.S. in chemical engineering at the University of Minnesota, and his M.B.A. at Harvard Business School.

Read More

Stephane Bancel Insider Trading History at Moderna

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/17/2021Sell9,000$174.28$1,568,520.006,444,868  
2/12/2021Sell11,046$181.98$2,010,151.086,453,868  
2/10/2021Sell9,000$182.74$1,644,660.006,454,868  
2/5/2021Sell11,046$174.61$1,928,742.066,463,868  
2/3/2021Sell9,000$156.51$1,408,590.006,464,868  
1/29/2021Sell11,046$173.25$1,913,719.506,473,868  
1/27/2021Sell9,000$151.27$1,361,430.006,474,868  
1/22/2021Sell11,046$131.81$1,455,973.266,483,868  
1/20/2021Sell9,000$124.51$1,120,590.006,484,868  
1/14/2021Sell20,000$117.08$2,341,600.006,494,868  
1/8/2021Sell11,046$114.02$1,259,464.926,503,868  
12/30/2020Sell9,000$118.27$1,064,430.006,514,868  
12/28/2020Sell11,046$116.44$1,286,196.246,523,868  
12/23/2020Sell9,000$120.00$1,080,000.006,524,868  
12/21/2020Sell4,729$141.12$667,356.486,533,868  
12/18/2020Sell11,046$139.60$1,542,021.606,533,868  
12/16/2020Sell9,000$137.51$1,237,590.006,534,868  
12/11/2020Sell11,046$159.18$1,758,302.286,543,868  
12/9/2020Sell9,000$170.00$1,530,000.006,544,868  
12/4/2020Sell21,046$148.11$3,117,123.066,553,868  
12/1/2020Sell3,929$178.00$699,362.006,554,868  
11/27/2020Sell21,046$119.23$2,509,314.586,563,868  
11/25/2020Sell9,000$99.20$892,800.006,564,868  
11/20/2020Sell17,514$95.10$1,665,581.406,573,868  
11/13/2020Sell21,046$86.04$1,810,797.84
11/11/2020Sell16,718$78.41$1,310,858.38
10/30/2020Sell11,046$68.36$755,104.566,603,868  
10/28/2020Sell9,000$68.75$618,750.006,604,868  
10/22/2020Sell10,000$68.58$685,800.006,614,868  
10/20/2020Sell8,455$72.05$609,182.756,614,868  
10/16/2020Sell11,046$75.02$828,670.926,623,868  
10/14/2020Sell9,000$79.81$718,290.006,624,868  
10/12/2020Sell19,265$73.26$1,411,353.90
10/8/2020Sell19,000$72.42$1,375,980.006,634,868  
10/2/2020Sell11,046$70.64$780,289.446,643,868  
9/30/2020Sell9,000$72.72$654,480.006,644,868  
9/24/2020Sell19,000$66.68$1,266,920.006,654,868  
9/21/2020Sell8,587$68.56$588,724.726,663,868  
9/18/2020Sell11,046$67.71$747,924.666,663,868  
9/16/2020Sell9,000$67.69$609,210.006,664,868  
9/11/2020Sell11,046$58.42$645,307.326,673,868  
9/4/2020Sell11,046$61.87$683,416.026,683,868  
9/2/2020Sell18,247$63.22$1,153,575.34
8/26/2020Sell9,000$67.45$607,050.006,694,868  
8/20/2020Sell27,824$67.46$1,877,007.046,703,868  
8/13/2020Sell19,000$72.22$1,372,180.006,663,858  
8/10/2020Sell19,143$74.23$1,420,984.89
8/5/2020Sell9,000$77.49$697,410.006,674,858  
8/3/2020Sell19,143$75.15$1,438,596.45
7/29/2020Sell9,000$82.00$738,000.006,684,858  
7/24/2020Sell11,046$71.56$790,451.766,693,858  
7/22/2020Sell9,000$79.61$716,490.006,694,858  
7/20/2020Sell6,326$83.53$528,410.786,703,858  
7/16/2020Sell19,000$83.92$1,594,480.006,704,858  
7/9/2020Sell10,000$62.04$620,400.006,713,858  
7/6/2020Sell11,046$59.53$657,568.386,714,858  
7/1/2020Sell9,000$62.92$566,280.006,715,858  
6/26/2020Sell11,046$60.65$669,939.906,724,858  
6/24/2020Sell9,000$63.25$569,250.006,725,858  
6/22/2020Sell4,521$65.92$298,024.326,734,858  
6/19/2020Sell11,046$64.61$713,682.066,734,858  
6/10/2020Sell3,435$58.80$201,978.006,734,858  
6/5/2020Sell11,046$57.85$639,011.106,734,858  
6/1/2020Sell4,878$62.67$305,704.266,729,980  
5/29/2020Sell11,046$58.02$640,888.926,729,980  
5/20/2020Sell4,186$70.00$293,020.006,734,858  
5/11/2020Sell3,376$59.57$201,108.326,685,053  
5/8/2020Sell11,046$56.53$624,430.386,685,053  
5/1/2020Sell4,349$48.70$211,796.306,688,429  
4/24/2020Sell11,046$47.15$520,818.906,692,778  
4/20/2020Sell4,269$45.00$192,105.006,692,778  
4/17/2020Sell11,046$46.35$511,982.106,692,778  
4/13/2020Sell3,139$32.00$100,448.006,699,983  
4/3/2020Sell11,046$32.81$362,419.266,703,122  
4/1/2020Sell3,339$30.05$100,336.956,703,122  
3/27/2020Sell11,046$28.37$313,375.026,706,461  
3/20/2020Sell3,537$29.13$103,032.816,706,461  
3/13/2020Sell11,046$21.17$233,843.826,709,998  
2/14/2020Sell11,046$19.02$210,094.926,727,934  
2/10/2020Sell4,303$23.50$101,120.506,737,237  
2/7/2020Sell4,876$23.00$112,148.006,737,237  
1/31/2020Sell11,046$20.43$225,669.786,742,113  
1/24/2020Sell11,046$21.22$234,396.126,742,113  
1/21/2020Sell4,850$20.79$100,831.506,757,511  
1/17/2020Sell11,046$20.96$231,524.166,757,511  
1/10/2020Sell16,482$20.24$333,595.686,762,500  
1/2/2020Sell5,114$19.57$100,080.986,762,500  
12/20/2019Sell11,046$19.69$217,495.746,762,500  
12/13/2019Sell11,046$18.53$204,682.386,762,500  
12/6/2019Sell11,046$20.01$221,030.466,720,368  
11/29/2019Sell11,046$20.54$226,884.846,720,368  
11/22/2019Sell11,046$20.48$226,222.086,720,368  
11/15/2019Sell11,046$19.97$220,588.62
11/8/2019Sell11,046$17.99$198,717.54
11/1/2019Sell11,046$16.89$186,566.94
See Full Table

Stephane Bancel Buying and Selling Activity at Moderna

Moderna Company Overview

Moderna logo
Moderna, Inc., a clinical stage biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, and cardiovascular diseases. As of February 15, 2019 the company had 11 programs in clinical trials and a total of 20 development candidates in six modalities comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company has strategic alliances with AstraZeneca, Merck & Co., Vertex Pharmaceuticals, Biomedical Advanced Research and Development Authority, Defense Advanced Research Projects Agency, and Bill & Melinda Gates Foundation; and a research collaboration with Harvard University. Moderna, Inc. also has collaborations with Lonza Ltd. for the manufacture of mRNA-1273, a COVID-19 vaccine; and Catalent for fill-finish manufacturing of its COVID-19 vaccine candidate. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Read More

Today's Range

Now: $144.79
$143.47
$151.00

50 Day Range

MA: $152.33
$112.75
$185.98

52 Week Range

Now: $144.79
$19.31
$189.26

Volume

9,422,439 shs

Average Volume

14,235,379 shs

Market Capitalization

$57.29 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.73
Elon Musk’s Next BIG Bet
First he bet it all on PayPal and made millions...

Then he bet it all on Tesla and made billions.

Now he’s going all-in again...
And this time he plans to dominate